Cardiocast

Biodegradable stent polymer offers no long-term protection


 

This week from MDedge Cardiology, a biodegradable polymer shows no long-term benefit in heart stents, appropriate use criteria for imaging in nonvalvular heart disease are released, ACOG updates guidance on hypertension in pregnancy, and more losartan lots are recalled.

Subscribe to Cardiocast wherever you get your podcasts.

Amazon AlexaApple Podcasts

Recommended Reading

Teva recalls valsartan-containing combo pills
MDedge Cardiology
Evidence coming on best preeclampsia treatment threshold
MDedge Cardiology
Barbershop BP intervention going strong at 12 months
MDedge Cardiology
Untreated OSA linked to resistant hypertension in black patients
MDedge Cardiology
Opioids don’t top NSAIDs for chronic pain
MDedge Cardiology
Firibastat looking good for difficult-to-treat hypertension
MDedge Cardiology
Cerebral small vessel disease progression linked to MCI in hypertensive patients
MDedge Cardiology
ACOG updates guidance on chronic hypertension in pregnancy, gestational hypertension
MDedge Cardiology
Torrent Pharmaceuticals expands losartan recall
MDedge Cardiology
Treprostinil improves function for complex PAH patients
MDedge Cardiology